Compare MEDP & NTNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | NTNX |
|---|---|---|
| Founded | 1992 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 12.4B |
| IPO Year | 2016 | 2015 |
| Metric | MEDP | NTNX |
|---|---|---|
| Price | $471.64 | $39.63 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 16 |
| Target Price | ★ $498.25 | $64.33 |
| AVG Volume (30 Days) | 435.8K | ★ 4.5M |
| Earning Date | 05-12-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.98 | ★ 227.45 |
| EPS | ★ 15.28 | 0.57 |
| Revenue | N/A | ★ $2,537,927,000.00 |
| Revenue This Year | $13.11 | $13.91 |
| Revenue Next Year | $7.51 | $13.28 |
| P/E Ratio | ★ $30.76 | $71.00 |
| Revenue Growth | N/A | ★ 18.11 |
| 52 Week Low | $250.05 | $35.39 |
| 52 Week High | $628.92 | $83.36 |
| Indicator | MEDP | NTNX |
|---|---|---|
| Relative Strength Index (RSI) | 43.76 | 43.96 |
| Support Level | $457.41 | $35.84 |
| Resistance Level | $501.30 | $42.63 |
| Average True Range (ATR) | 17.34 | 1.86 |
| MACD | 7.68 | 0.38 |
| Stochastic Oscillator | 87.87 | 54.74 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company operates a single operating and reportable segment based on a subscription business model. It conducts business in the United States, Europe, the Middle East and Africa, Asia Pacific, and other Americas, with key revenue generated from the United States.